Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
British Journal of Clinical Pharmacology|March 6, 2008
Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjectsBo-Hyung Kim, Hyeong-Seok Lim, Jae-Yong Chung, et al.
Clinical Pharmacology and Therapeutics|November 13, 2004
A variant 2677A allele of the MDR1 gene affects fexofenadine dispositionSo-Young Yi, Kyoung-Sup Hong, Hyeong-Seok Lim, et al.
Plos One|December 19, 2013
Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomasJung Ryul Kim, Young Jae Moon, Keun Sang Kwon, et al.
Translational Oncology|August 28, 2015
Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma PatientsSee-Hyoung Park, Sang Jae Noh, Kyoung Min Kim, et al.
Bone|February 13, 2010
COMP-angiopoietin-1 accelerates bone formation during distraction osteogenesisByung-Hyun Park, Sun Jung Yoon, Kyu Yun Jang, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteersKyoung Soo Lim, Joo-Youn Cho, Bo-Hyung Kim, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesKyung-Sang Yu, Joo-Youn Cho, In-Jin Jang, et al.
Plos One|September 11, 2013
Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomasJung Ryul Kim, Young Jae Moon, Keun Sang Kwon, et al.
Pageof 15